Influence of multi-morbidity in the effectiveness of transitional-care heart failure programmes: a population-based study with longitudinal real-world data in 77,554 patients.
Event: Heart Failure 2023
Topic: Multidisciplinary Interventions
Session: Chronic heart failure - rehabilitation
Implications of levels of hyperkalemia in the risk of renin-angiotensin-aldosterone system inhibitors interruption/down-titration and mortality in patients with chronic cardiovascular conditions
Event: Heart Failure 2023
Topic: Angiotensin-Renin-Bradykinin System
Session: Comorbidities
Management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure - Epidemiology, prognosis, outcome 1
Implications of hyperkalemia in the management of renin-angiotensin-aldosterone system inhibitors in patients with chronic cardiovascular conditions and its association with clinical outcomes
Event: Heart Failure 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Heart Failure ePosters - focus on Chronic Heart Failure 9
36,269 patients with chronic cardiovascular, metabolic and renal conditions: impact on clinical outcomes, medical resource use and health-related costs of deranged serum potassium levels
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Changing Epidemiology of Heart Failure
A population-based analysis in 375,233 cases of heart failure stages A, B and C. Real world epidemiology of prevalence and temporal trends in South-European populations
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic Heart Failure ePosters
Epidemiology of potassium derangements among chronic cardiovascular, metabolic and renal conditions: a population-based analysis data from more than 375,000 individuals
Event: ESC Congress 2020
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic Heart Failure ePosters
Impact on clinical events and healthcare costs of adding telemedicine to multidisciplinary care of patients with heart failure and mid-range or preserved LVEF: a randomised controlled trial
Event: ESC Congress 2017
Topic: AHF - Non pharmacological treatment
Session: Acute Heart Failure (AHF)
ESC 365 is supported by
